Cervavac Quadrivalent Human Papillomavirus Vaccine

Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16 and 18.
Genital warts (condyloma acuminata) caused by HPV types 6 and 11.
Cervavac  is indicated in boys and men 9 through 26 years of age for the prevention of the following diseases caused by HPV types included in the vaccine:
Anal cancer caused by HPV types 16 and 18.
Genital warts (condyloma acuminata) caused by HPV types 6 and 11.